Topic
Bosaya
News
8 Apr 2026
Biocon Announces U.S. Commercial Launch of Bosaya™ and Aukelso™, Denosumab Biosimilars
Biocon Limited has today announced the commercial launch of Bosaya™ (denosumab-kyqq) and Aukelso™ (denosumab-kyqq) in the United States. Bosaya™ (biosimilar…
Global News
18 Sep 2025
Biocon Biologics receives USFDA approval for Bosaya and Aukelso, Denosumab biosimilars
In addition, the US FDA granted a provisional interchangeability designation for both BOSAYA andAUKELSO Biocon Biologics Ltd (BBL) announced that…